CD4+ T Cell-Mediated Immunity against the Phagosomal Pathogen Leishmania: Implications for Vaccination

Sallusto, 2010, From vaccines to memory and back, Immunity, 33, 451, 10.1016/j.immuni.2010.10.008 Netea, 2011, Trained immunity: a memory for innate host defense, Cell Host Microbe, 9, 355, 10.1016/j.chom.2011.04.006 Nunes-Alves, 2014, In search of a new paradigm for protective immunity to TB, Nat. Rev. Microbiol., 12, 289, 10.1038/nrmicro3230 Divangahi, 2018, Cracking the vaccine code in tuberculosis, Am. J. Respir. Crit. Care Med., 197, 427, 10.1164/rccm.201707-1489PP da Costa, 2014, Recombinant BCG: innovations on an old vaccine: scope of BCG strains and strategies to improve long-lasting memory, Front. Immunol., 5, 152, 10.3389/fimmu.2014.00152 Zinkernagel, 2012, Immunological memory ≠ protective immunity, Cell. Mol. Life Sci., 69, 1635, 10.1007/s00018-012-0972-y Peters, 2008, In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies, Science, 321, 970, 10.1126/science.1159194 Dey, 2018, Gut microbes egested during bites of infected sand flies augment severity of leishmaniasis via inflammasome-derived IL-1beta, Cell Host Microbe, 23, 134, 10.1016/j.chom.2017.12.002 Kimblin, 2008, Quantification of the infectious dose of Leishmania major transmitted to the skin by single sand flies, Proc. Natl. Acad. Sci. U. S. A., 105, 10125, 10.1073/pnas.0802331105 Ribeiro-Gomes, 2014, Site-dependent recruitment of inflammatory cells determines the effective dose of Leishmania major, Infect. Immun., 82, 2713, 10.1128/IAI.01600-13 Thalhofer, 2011, Leukocytes infiltrate the skin and draining lymph nodes in response to the protozoan Leishmania infantum chagasi, Infect. Immun., 79, 108, 10.1128/IAI.00338-10 Hurrell, 2015, Rapid sequestration of Leishmania mexicana by neutrophils contributes to the development of chronic lesion, PLoS Pathog., 11, 10.1371/journal.ppat.1004929 Romano, 2017, Divergent roles for Ly6C+CCR2+CX3CR1+ inflammatory monocytes during primary or secondary infection of the skin with the intra-phagosomal pathogen Leishmania major, PLoS Pathog., 13, 10.1371/journal.ppat.1006479 Kinchen, 2008, Phagosome maturation: going through the acid test, Nat. Rev. Mol. Cell Biol., 9, 781, 10.1038/nrm2515 Ray, 2012, Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling, Cell Signal., 24, 981, 10.1016/j.cellsig.2012.01.008 Gupta, 2013, Mechanisms of immune evasion in leishmaniasis, 155, 10.1016/B978-0-12-407679-2.00005-3 Goldberg, 2014, Evasion of innate and adaptive immunity by Mycobacterium tuberculosis, Microbiol. Spectr., 2, 5, 10.1128/microbiolspec.MGM2-0005-2013 Arango Duque, 2015, Leishmania survival in the macrophage: where the ends justify the means, Curr. Opin. Microbiol., 26, 32, 10.1016/j.mib.2015.04.007 Matte, 2016, Leishmania major promastigotes evade LC3-associated phagocytosis through the action of GP63, PLoS Pathog., 12, 10.1371/journal.ppat.1005690 Carneiro, 2017, Use of two-photon microscopy to study Leishmania major infection of the skin, Methods, 127, 45, 10.1016/j.ymeth.2017.04.012 De Trez, 2009, iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice, PLoS Pathog., 5, 10.1371/journal.ppat.1000494 Mandell, 2017, Continual renewal and replication of persistent Leishmania major parasites in concomitantly immune hosts, Proc. Natl. Acad. Sci. U. S. A., 114, E801, 10.1073/pnas.1619265114 Heyde, 2018, CD11c-expressing Ly6C+CCR2+ monocytes constitute a reservoir for efficient Leishmania proliferation and cell-to-cell transmission, PLoS Pathog., 14, 10.1371/journal.ppat.1007374 Hurrell, 2017, Frontline science: Leishmania mexicana amastigotes can replicate within neutrophils, J. Leukoc. Biol., 102, 1187, 10.1189/jlb.4HI0417-158R Serafim, 2017, Unique features of vector-transmitted leishmaniasis and their relevance to disease transmission and control, Vol. 2, 91 Meier, 2003, Leishmania-induced inhibition of macrophage antigen presentation analyzed at the single-cell level, J. Immunol., 171, 6706, 10.4049/jimmunol.171.12.6706 Matheoud, 2013, Leishmania evades host immunity by inhibiting antigen cross-presentation through direct cleavage of the SNARE VAMP8, Cell Host Microbe, 14, 15, 10.1016/j.chom.2013.06.003 Tubo, 2014, CD4+ T cells: guardians of the phagosome, Clin. Microbiol. Rev., 27, 200, 10.1128/CMR.00097-13 Müller Andreas, 2012, CD4+ T cells rely on a cytokine gradient to control intracellular pathogens beyond sites of antigen presentation, Immunity, 37, 147, 10.1016/j.immuni.2012.05.015 Houde, 2003, Phagosomes are competent organelles for antigen cross-presentation, Nature, 425, 402, 10.1038/nature01912 Stäger, 2012, CD8+ T cells in Leishmania infections: friends or foes?, Front. Immunol., 3, 5, 10.3389/fimmu.2012.00005 Casadevall, 2003, Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle, Infect. Immun., 71, 4225, 10.1128/IAI.71.8.4225-4228.2003 Peters, 2014, Chronic parasitic infection maintains high frequencies of short-lived Ly6C+CD4+ effector T cells that are required for protection against re-infection, PLoS Pathog., 10, 10.1371/journal.ppat.1004538 Olekhnovitch, 2015, Induction, propagation, and activity of host nitric oxide: lessons from Leishmania infection, Trends Parasitol., 31, 653, 10.1016/j.pt.2015.08.001 Scott, 1988, Immunoregulation of cutaneous leishmaniasis: T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens, J. Exp. Med., 168, 1675, 10.1084/jem.168.5.1675 Glennie, 2017, Skin-resident CD4+ T cells protect against Leishmania major by recruiting and activating inflammatory monocytes, PLoS Pathog., 13, 10.1371/journal.ppat.1006349 Blos, 2003, Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase, Eur. J. Immunol., 33, 1224, 10.1002/eji.200323825 Schleicher, 2016, TNF-mediated restriction of arginase 1 expression in myeloid cells triggers type 2 NO synthase activity at the site of infection, Cell Rep., 15, 1062, 10.1016/j.celrep.2016.04.001 Qadoumi, 2002, Expression of inducible nitric oxide synthase in skin lesions of patients with American cutaneous leishmaniasis, Infect. Immun., 70, 4638, 10.1128/IAI.70.8.4638-4642.2002 Nylén, 2007, Interleukin-10 and the pathogenesis of human visceral leishmaniasis, Trends Immunol., 28, 378, 10.1016/j.it.2007.07.004 Belkaid, 2002, CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity, Nature, 420, 502, 10.1038/nature01152 Peters, 2006, Immune privilege in sites of chronic infection: Leishmania and regulatory T cells, Immunol. Rev., 213, 159, 10.1111/j.1600-065X.2006.00432.x Anderson, 2005, Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice, J. Immunol., 174, 2934, 10.4049/jimmunol.174.5.2934 Lee, 2018, Mannose receptor high, M2 dermal macrophages mediate nonhealing Leishmania major infection in a Th1 immune environment, J. Exp. Med., 215, 357, 10.1084/jem.20171389 Peters, 2009, Vector transmission of Leishmania abrogates vaccine-induced protective immunity, PLoS Pathog., 5, 10.1371/journal.ppat.1000484 Peters, 2012, Evaluation of recombinant Leishmania polyprotein plus glucopyranosyl lipid A stable emulsion vaccines against sand fly-transmitted Leishmania major in C57BL/6 mice, J. Immunol., 189, 4832, 10.4049/jimmunol.1201676 Greenblatt, 1980, The present and future of vaccination for cutaneous leishmaniasis, Prog. Clin. Biol. Res., 47, 259 Kellina, 1981, Problem and current lines in investigations on the epidemiology of leishmaniasis and its control in the U.S.S.R, Bull. Soc. Pathol. Exot. Fil., 74, 306 Nadim, 1983, Effectiveness of leishmanization in the control of cutaneous leishmaniasis, Bull. Soc. Pathol. Exot. Fil., 76, 377 Handman, 2001, Leishmaniasis: current status of vaccine development, Clin. Microbiol. Rev., 14, 229, 10.1128/CMR.14.2.229-243.2001 Romano, 2015, Cutaneous infection with Leishmania major mediates heterologous protection against visceral infection with Leishmania infantum, J. Immunol., 195, 3816, 10.4049/jimmunol.1500752 Zijlstra, 1994, Endemic Kala-Azar in Eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis, Am. J. Trop. Med. Hyg., 51, 826, 10.4269/ajtmh.1994.51.826 Ranasinghe, 2012, Leishmania donovani zymodeme MON-37 isolated from an autochthonous visceral leishmaniasis patient in Sri Lanka, Pathog. Glob. Health, 106, 421, 10.1179/2047773212Y.0000000054 Cadena, 2018, Concurrent infection with Mycobacterium tuberculosis confers robust protection against secondary infection in macaques, PLoS Pathog., 14, 10.1371/journal.ppat.1007305 Nelson, 2013, CD4+ T cell persistence and function after infection are maintained by low-level peptide:MHC class II presentation, J. Immunol., 190, 2828, 10.4049/jimmunol.1202183 Okwor, 2014, CD8+ T cells are preferentially activated during primary low dose Leishmania major infection but are completely dispensable during secondary anti-Leishmania immunity, PLoS Negl. Trop. Dis., 8, 10.1371/journal.pntd.0003300 Zaph, 2004, Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites, Nat. Med., 10, 1104, 10.1038/nm1108 Khamesipour, 2005, Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis, Vaccine, 23, 3642, 10.1016/j.vaccine.2005.02.015 Sergiev, 1992, Control and prophylaxis of cutaneous leishmaniasis in the middle Asia republics of the former USSR, Bull. Soc. Fr. Parasitol., 10, 183 Sergiev, 2018, Epidemiology and control of leishmaniasis in the former USSR: a review article, Iran. J. Parasitol., 13, 342 Costa, 2011, Vaccines for the leishmaniases: proposals for a research agenda, PLoS Negl. Trop. Dis., 5, e943, 10.1371/journal.pntd.0000943 Osman, 2017, A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH, PLOS Negl. Trop. Dis., 11, 10.1371/journal.pntd.0005527 Duthie, 2018, Heterologous immunization with defined RNA and subunit vaccines enhances T cell responses that protect against Leishmania donovani, Front. Immunol., 9, 2420, 10.3389/fimmu.2018.02420 Duthie, 2017, A defined subunit vaccine that protects against vector-borne visceral leishmaniasis, npj Vaccines, 2, 23, 10.1038/s41541-017-0025-5 Sacks, 2016 Reed, 2016, Leishmania vaccine development: exploiting the host–vector–parasite interface, Expert Rev. Vaccines, 15, 81, 10.1586/14760584.2016.1105135 Coler, 2015, From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE, Clin. Transl. Immunol., 4, e35, 10.1038/cti.2015.6 Noazin, 2008, First generation leishmaniasis vaccines: a review of field efficacy trials, Vaccine, 26, 6759, 10.1016/j.vaccine.2008.09.085 Gomes, 2012, KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi, PLoS Negl. Trop. Dis., 6, 10.1371/journal.pntd.0001610 Mou, 2015, Identification of broadly conserved cross-species protective Leishmania antigen and its responding CD4+ T cells, Sci. Transl. Med., 7, 10.1126/scitranslmed.aac5477 Darrah, 2007, Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major, Nat. Med., 13, 843, 10.1038/nm1592 Rhee, 2002, Vaccination with heat-killed Leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against Leishmania major infection, J. Exp. Med., 195, 1565, 10.1084/jem.20020147 Rogers, 2006, Synthetic glycovaccine protects against the bite of Leishmania-infected sand flies, J. Infect. Dis., 194, 512, 10.1086/505584 Murray, 2005, Advances in leishmaniasis, Lancet, 366, 1561, 10.1016/S0140-6736(05)67629-5 Goto, 2011, KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis, Clin. Vaccine Immunol., 18, 1118, 10.1128/CVI.05024-11 Coler, 2007, Leish-111f, a recombinant polyprotein vaccine that protects against visceral leishmaniasis by elicitation of CD4+ T cells, Infect. Immun., 75, 4648, 10.1128/IAI.00394-07 Tabbara, 2005, Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection, Infect. Immun., 73, 4714, 10.1128/IAI.73.8.4714-4722.2005 Glennie, 2015, Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection, J. Exp. Med., 212, 1405, 10.1084/jem.20142101 Marshall, 2011, Differential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4(+) cell properties during viral infection, Immunity, 35, 633, 10.1016/j.immuni.2011.08.016 DeLong, 2018, Cytokine- and TCR-mediated regulation of T cell expression of Ly6C and Sca-1, J. Immunol., 200, 1761, 10.4049/jimmunol.1701154 Chang, 2017, Dichotomous expression of TNF superfamily ligands on antigen-presenting cells controls post-priming anti-viral CD4+ T cell immunity, Immunity, 47, 943, 10.1016/j.immuni.2017.10.014 Uzonna, 2001, Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease, J. Immunol., 167, 6967, 10.4049/jimmunol.167.12.6967 Belkaid, 2001, The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure, J. Exp. Med., 194, 1497, 10.1084/jem.194.10.1497 Mendez, 2004, Role for CD4+CD25+ regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity, J. Exp. Med., 200, 201, 10.1084/jem.20040298 Jameson, 2018, Understanding subset diversity in T cell memory, Immunity, 48, 214, 10.1016/j.immuni.2018.02.010 Moore, 2016, CD4+ Recent thymic emigrants are recruited into granulomas during Leishmania donovani infection but have limited capacity for cytokine production, PLoS One, 11, 10.1371/journal.pone.0163604 Scott-Browne, 2016, Dynamic changes in chromatin accessibility occur in CD8+ T cells responding to viral infection, Immunity, 45, 1327, 10.1016/j.immuni.2016.10.028 Ribeiro-Gomes, 2012, Efficient capture of infected neutrophils by dendritic cells in the skin inhibits the early anti-Leishmania response, PLoS Pathog., 8, 10.1371/journal.ppat.1002536 Ribeiro-Gomes, 2015, Apoptotic cell clearance of Leishmania major-infected neutrophils by dendritic cells inhibits CD8(+) T-cell priming in vitro by Mer tyrosine kinase-dependent signaling, Cell Death Dis., 6, 10.1038/cddis.2015.351 Kima, 1996, Leishmania-infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells, Eur. J. Immunol., 26, 3163, 10.1002/eji.1830261249 Belkaid, 2000, A natural model of Leishmania major infection reveals a prolonged ‘silent’ phase of parasite amplification in the skin before the onset of lesion formation and immunity, J. Immunol., 165, 969, 10.4049/jimmunol.165.2.969 Moradin, 2012, Leishmania promastigotes: building a safe niche within macrophages, Front. Cell. Infect. Microbiol., 2, 10.3389/fcimb.2012.00121 Dandekar, 2012, Salmonella enterica: a surprisingly well-adapted intracellular lifestyle, Front. Microbiol., 3, 164, 10.3389/fmicb.2012.00164 Smith, 2003, Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence, Clin. Microbiol. Rev., 16, 463, 10.1128/CMR.16.3.463-496.2003 Reiling, 2018, Shaping the niche in macrophages: genetic diversity of the M. tuberculosis complex and its consequences for the infected host, Int. J. Med. Microbiol., 308, 118, 10.1016/j.ijmm.2017.09.009 DeLeon-Rodriguez, 2016, Cryptococcus neoformans: tripping on acid in the phagolysosome, Front. Microbiol., 7, 164, 10.3389/fmicb.2016.00164 Alvar, 2012, Leishmaniasis worldwide and global estimates of its incidence, PLoS One, 7, 10.1371/journal.pone.0035671 Burza, 2018, Leishmaniasis, Lancet, 392, 951, 10.1016/S0140-6736(18)31204-2 Titus, 1988, Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity, Science, 239, 1306, 10.1126/science.3344436 Belkaid, 1998, Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis, J. Exp. Med., 188, 1941, 10.1084/jem.188.10.1941 Giraud, 2018, Leishmania proteophosphoglycans regurgitated from infected sand flies accelerate dermal wound repair and exacerbate leishmaniasis via insulin-like growth factor 1-dependent signalling, PLoS Pathog., 14, 10.1371/journal.ppat.1006794 Rogers, 2004, Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG, Nature, 430, 463, 10.1038/nature02675 Hartley, 2016, Leishmaniavirus-dependent metastatic leishmaniasis is prevented by blocking IL-17A, PLoS Pathog., 12, 10.1371/journal.ppat.1005852 Naik, 2012, Compartmentalized control of skin immunity by resident commensals, Science, 337, 1115, 10.1126/science.1225152 Gimblet, 2017, Cutaneous leishmaniasis induces a transmissible dysbiotic skin microbiota that promotes skin inflammation, Cell Host Microbe, 22, 13, 10.1016/j.chom.2017.06.006 Atayde, 2015, Exosome secretion by the parasitic protozoan Leishmania within the sand fly midgut, Cell Rep., 13, 957, 10.1016/j.celrep.2015.09.058 Sacks, 2014, Vaccines against tropical parasitic diseases: a persisting answer to a persisting problem, Nat. Immunol., 15, 403, 10.1038/ni.2853 Selvapandiyan, 2009, Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis, J. Immunol., 183, 1813, 10.4049/jimmunol.0900276